Organigram Global Balance Sheet Health
Financial Health criteria checks 4/6
Organigram Global has a total shareholder equity of CA$425.6M and total debt of CA$55.0K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are CA$537.9M and CA$112.3M respectively.
Key information
0.013%
Debt to equity ratio
CA$55.00k
Debt
| Interest coverage ratio | n/a |
| Cash | CA$14.05m |
| Equity | CA$425.60m |
| Total liabilities | CA$112.30m |
| Total assets | CA$537.90m |
Recent financial health updates
Recent updates
Organigram Global Reports Record Q2 2025 Revenues As Global Footprint Expands
May 16Organigram Is A Small-Cap Bargain
Feb 23Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade)
Dec 22Organigram Could Soar In 2026
Dec 01Organigram: Why I Still Like It
Sep 15Organigram: Q3 2024 Earnings Show Improvement In Revenues And Net Income (Hold)
Aug 14Organigram Has Declined A Lot And Is A Great Deal
Jun 23Organigram: Operating In A Structurally Challenged Industry
Apr 20Don't Rule Out A Bull Market (Podcast Transcript)
Aug 02Don't Rule Out A Bull Market
Jul 27Organigram revenue of $38.12M beats by $12.05M, sees Q4 revenue higher than Q3
Jul 14OrganiGram: Canadian Cannabis Remains Tough To Own
Apr 26Why OrganiGram Should Generate Consistent Growth Going Forward
Jan 16OrganiGram: Positive Signs, But Struggles Persist
Jul 14Financial Position Analysis
Short Term Liabilities: OGI's short term assets (CA$258.5M) exceed its short term liabilities (CA$75.6M).
Long Term Liabilities: OGI's short term assets (CA$258.5M) exceed its long term liabilities (CA$36.7M).
Debt to Equity History and Analysis
Debt Level: OGI has more cash than its total debt.
Reducing Debt: OGI's debt to equity ratio has reduced from 23.8% to 0.01% over the past 5 years.
Debt Coverage: OGI's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if OGI's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 22:08 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Organigram Global Inc. is covered by 19 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Frederico Yokota Choucair Gomes | ATB Capital Markets |
| Tamy Chen | BMO Capital Markets Equity Research |